Coherus Biosciences is a biopharmaceutical company that develops and commercializes high-quality biosimilar therapeutics. The company’s mission is to increase access to biologic medicines, including biosimilar versions of complex drugs, while maintaining the highest standards of product quality, safety, and efficacy. Coherus’ portfolio includes biosimilar versions of drugs for cancer, autoimmune diseases, and other chronic conditions. The company is committed to using innovative technologies and processes to make biosimilars more accessible and affordable for patients around the world. Coherus is headquartered in Redwood City, California, and has operations in the United States, Europe, and Asia.